Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 316 participants.
Also called NCT06091176
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 316 participants
- Sponsor
- Newel Health SRL
- Registry
-
NCT06091176
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT06091176. Randomized; double masking; primary purpose treatment. Start 2024-11-01 (anticipated); primary completion 2025-07-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension
- Condition
- Essential Hypertension
- Condition
- Primary Hypertension
- Intervention (Device)
- Amicomed®
- Intervention (Device)
- Digital Placebo
- Intervention (Other)
- Usual Care
- Lead sponsor
- Newel Health SRL
Record details
- Record id
cardio:ct-nct06091176- Content hash
4e6a9e5e807a34862714eeacbba369d63eb7ddf5aec86723070318b0301a94b2